Who is sponsoring NCT05077644?

NCT05077644 is sponsored by Curio Digital Therapeutics, Inc..

What drugs are being tested in NCT05077644?

Interventions in NCT05077644: Stella (TM) Mobile Application.

What condition does NCT05077644 study?

NCT05077644 studies Post-partum Depression.

Is NCT05077644 still recruiting?

NCT05077644 is currently status unknown. Last updated 14 October 2021.

Last reviewed 2021-10-14 · How we verify

NCT05077644

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD)

Status unknown NA Last updated 14 October 2021

What this trial tests

NA trial testing Stella (TM) Mobile Application in Post-partum Depression in 65 participants. Status unknown.

Timeline

1 October 2021

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Curio Digital Therapeutics, Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	65
Start date	1 October 2021
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across United States

Drugs / interventions tested

Stella (TM) Mobile Application

Conditions studied

Post-partum Depression — all drugs for Post-partum Depression →

Sponsor

Curio Digital Therapeutics, Inc.

Who can join

Adults 18 to 50, female only, with Post-partum Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary Objective: Evaluate the user experience with the Stella (TM) app for the management of Postpartum Depression in an observed population for 8 calendar weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05077644 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Curio Digital Therapeutics, Inc.
Last refreshed: 14 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05077644.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing